Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigurdur Olafsson

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Gastroenterology|April 27, 2024
Incidence of cirrhosis in Iceland-impact of the TraP HepC nationwide HCV elimination programHalldor A Haraldsson, Sigurdur Olafsson, Magnus Gottfredsson, et al.
Journal of Clinical Medicine|June 13, 2025
Clinically Important Decrease in Liver Stiffness Following Treatment for Hepatitis C: Outcome of the TraP HepC Nationwide Elimination ProgramSmári Freyr Kristjánsson, Sigurdur Olafsson, Magnús Gottfredsson, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitisKristjan T Örnolfsson, Sigurdur Olafsson, Ottar M Bergmann, et al.
Scandinavian Journal of Gastroenterology|May 11, 2019
Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based studyKristjan T Örnolfsson, Sigrun H Lund, Sigurdur Olafsson, et al.
Gastroenterology|February 20, 2013
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of IcelandEinar S Björnsson, Ottar M Bergmann, Helgi K Björnsson, et al.
Scandinavian Journal of Gastroenterology|May 14, 2009
Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomesSteingerdur Anna Gunnarsdottir, Rolf Olsson, Sigurdur Olafsson, et al.
The American Journal of Gastroenterology|November 24, 2004
Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relativesSigurdur Olafsson, Hallgrimur Gudjonsson, Carlo Selmi, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
A nationwide population-based prospective study of cirrhosis in IcelandSigurdur Olafsson, Sigurjon Rögnvaldsson, Ottar M Bergmann, et al.
Laeknabladid|September 5, 2019
[Primary sclerosing cholangitis in Iceland 1992-2012]Hafsteinn Oli Gudnason, Jon Orvar Kristinsson, Ottar Mar Bergmann, et al.
Scandinavian Journal of Gastroenterology|March 10, 2017
Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver diseaseJon Kristinn Nielsen, Sigurdur Olafsson, Ottar M Bergmann, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Gastroenterology|April 27, 2024
Incidence of cirrhosis in Iceland-impact of the TraP HepC nationwide HCV elimination programHalldor A Haraldsson, Sigurdur Olafsson, Magnus Gottfredsson, et al.
Journal of Clinical Medicine|June 13, 2025
Clinically Important Decrease in Liver Stiffness Following Treatment for Hepatitis C: Outcome of the TraP HepC Nationwide Elimination ProgramSmári Freyr Kristjánsson, Sigurdur Olafsson, Magnús Gottfredsson, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitisKristjan T Örnolfsson, Sigurdur Olafsson, Ottar M Bergmann, et al.
Scandinavian Journal of Gastroenterology|May 11, 2019
Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based studyKristjan T Örnolfsson, Sigrun H Lund, Sigurdur Olafsson, et al.
Gastroenterology|February 20, 2013
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of IcelandEinar S Björnsson, Ottar M Bergmann, Helgi K Björnsson, et al.
Scandinavian Journal of Gastroenterology|May 14, 2009
Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomesSteingerdur Anna Gunnarsdottir, Rolf Olsson, Sigurdur Olafsson, et al.
The American Journal of Gastroenterology|November 24, 2004
Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relativesSigurdur Olafsson, Hallgrimur Gudjonsson, Carlo Selmi, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
A nationwide population-based prospective study of cirrhosis in IcelandSigurdur Olafsson, Sigurjon Rögnvaldsson, Ottar M Bergmann, et al.
Laeknabladid|September 5, 2019
[Primary sclerosing cholangitis in Iceland 1992-2012]Hafsteinn Oli Gudnason, Jon Orvar Kristinsson, Ottar Mar Bergmann, et al.
Scandinavian Journal of Gastroenterology|March 10, 2017
Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver diseaseJon Kristinn Nielsen, Sigurdur Olafsson, Ottar M Bergmann, et al.
Pageof 4